NREF awards UC medical student neurosurgery research fellowship
One-year award to further research into a cure for specific glioma
The Neurosurgery Research and Education Foundation partnered with the Brain Tumor Foundation Medical Student Summer Research Fellowship and awarded second-year University of Cincinnati medical student Troy Carnwath a $2,500 fellowship.
Troy Carnwath, second-year medical student at the University of Cincinnati College of Medicine. Photo provided by Troy Carnwath.
“I was ecstatic,” says Carnwath, “actually that’s an understatement.” He embarrassedly admitted he was running around his apartment shouting with excitement.
That one-year fellowship allowed Carnwath to assist Matthew Garrett, MD, PhD, in a research project focused on a particular type of brain cancer called IDH1 mutant glioma. “These particular gliomas behave a little bit differently,” Carnwath explains, “at least at the molecular level.”
Through a drug screen, Garrett and Carnwath identified inhibitors of histone deacetylase, or the HDAC family of enzyme, as specifically effective in stopping these tumors. “The problem is though,” says Carnwath, "there is not just one HDAC enzyme, there are actually 18.”
They had to eliminate each enzyme one-by-one, which brought in Carnwath’s computer-coding skills. “I was able to do the sequencing analysis,” he explains, “which is pretty complex.”
Garrett was impressed by Troy's work. "It takes many people years if not decades to learn the coding skills that Troy acquired during his undergraduate experience and during this fellowship," he said. "They have multiple applications and will make Troy a highly sought-after collaborator throughout his career."
Matthew Garrett, MD, PhD in his lab. Photo by Julie Forbes.
They were able to single out each enzyme and analyze how it impacted cancer progression. Through this study, they were able to identify HDAC1 as the most critical member of the HDAC family. Garrett and Carnwath predict that the loss of the HDAC1 gene in these tumors will significantly extend survival in a mouse model of these tumors.
Carnwath has a strong interest in going into neurosurgery residency after medical school, specifically with a focus on neuro-oncology.
This is the first year that the Southeastern Brain Tumor Fund partnered with NREF to provide this fellowship and a representative said the organization was greatly moved by Carnwath’s application and are honored to provide the support.
Featured photo at top of laboratory. Photo/Julie Forbes/University of Cincinnati.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
UC Board votes to fund design for YMCA renovation
October 28, 2025
At its October 28, 2025 meeting, the University of Cincinnati Board of Trustees approved $5 million in funding to complete all design and pre-construction services required to renovate the interior of a former YMCA building located at 270 Calhoun Street.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.